Clinical pharmacology of intravitreal anti-VEGF drugs
Clinical efficacy of intravitreal anti-VEGF drugs has been widely demonstrated in several
angiogenesis-driven eye diseases including diabetic macular edema and the neovascular …
angiogenesis-driven eye diseases including diabetic macular edema and the neovascular …
[引用][C] Clinical pharmacology of intravitreal anti-VEGF drugs
S Fogli, M Del Re, E Rofi, C Posarelli, M Figus… - Eye, 2018 - cir.nii.ac.jp
Clinical pharmacology of intravitreal anti-VEGF drugs | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
[PDF][PDF] Clinical pharmacology of intravitreal anti-VEGF drugs
S Fogli, M Del Re, E Rofi, C Posarelli, M Figus… - 2018 - researchgate.net
Clinical efficacy of intravitreal anti-VEGF drugs has been widely demonstrated in several
angiogenesis-driven eye diseases including diabetic macular edema and the neovascular …
angiogenesis-driven eye diseases including diabetic macular edema and the neovascular …
Clinical pharmacology of intravitreal anti-VEGF drugs
S Fogli, M Del Re, E Rofi, C Posarelli… - Eye (London …, 2018 - pubmed.ncbi.nlm.nih.gov
Clinical efficacy of intravitreal anti-VEGF drugs has been widely demonstrated in several
angiogenesis-driven eye diseases including diabetic macular edema and the neovascular …
angiogenesis-driven eye diseases including diabetic macular edema and the neovascular …
Clinical pharmacology of intravitreal anti-VEGF drugs
S Fogli, M Del Re, E Rofi, C Posarelli, M Figus… - EYE, 2018 - arpi.unipi.it
Clinical efficacy of intravitreal anti-VEGF drugs has been widely demonstrated in several
angiogenesis-driven eye diseases including diabetic macular edema and the neovascular …
angiogenesis-driven eye diseases including diabetic macular edema and the neovascular …
Clinical pharmacology of intravitreal anti-VEGF drugs.
S Fogli, M Del Re, E Rofi, C Posarelli, M Figus… - Eye (London …, 2018 - europepmc.org
Clinical efficacy of intravitreal anti-VEGF drugs has been widely demonstrated in several
angiogenesis-driven eye diseases including diabetic macular edema and the neovascular …
angiogenesis-driven eye diseases including diabetic macular edema and the neovascular …
[HTML][HTML] Clinical pharmacology of intravitreal anti-VEGF drugs
S Fogli, M Del Re, E Rofi, C Posarelli, M Figus… - Eye, 2018 - ncbi.nlm.nih.gov
Clinical efficacy of intravitreal anti-VEGF drugs has been widely demonstrated in several
angiogenesis-driven eye diseases including diabetic macular edema and the neovascular …
angiogenesis-driven eye diseases including diabetic macular edema and the neovascular …
Clinical pharmacology of intravitreal anti-VEGF drugs.
S Fogli, M Del Re, E Rofi, C Posarelli, M Figus… - Eye (London …, 2018 - europepmc.org
Clinical efficacy of intravitreal anti-VEGF drugs has been widely demonstrated in several
angiogenesis-driven eye diseases including diabetic macular edema and the neovascular …
angiogenesis-driven eye diseases including diabetic macular edema and the neovascular …
[PDF][PDF] Clinical pharmacology of intravitreal anti-VEGF drugs
S Fogli, M Del Re, E Rofi, C Posarelli, M Figus… - 2018 - researchgate.net
Clinical efficacy of intravitreal anti-VEGF drugs has been widely demonstrated in several
angiogenesis-driven eye diseases including diabetic macular edema and the neovascular …
angiogenesis-driven eye diseases including diabetic macular edema and the neovascular …